120 related articles for article (PubMed ID: 5098699)
1. Trifluoroethanol and halothane biotransformation in man.
Cascorbi HF; Blake DA
Anesthesiology; 1971 Nov; 35(5):493-5. PubMed ID: 5098699
[No Abstract] [Full Text] [Related]
2. Qualitative analysis of halothane metabolites in man.
Blake DA; Barry JQ; Cascobi HF
Anesthesiology; 1972 Feb; 36(2):152-4. PubMed ID: 4550951
[No Abstract] [Full Text] [Related]
3. Biotransformation of fluroxene.
Cascorbi HF
Int Anesthesiol Clin; 1974; 12(2):107-10. PubMed ID: 4152554
[No Abstract] [Full Text] [Related]
4. Halothane biotransformation in man.
Cascorbi HF; Vesell ES; Blake DA; Helrich M
Ann N Y Acad Sci; 1971 Jul; 179():244-8. PubMed ID: 5285377
[No Abstract] [Full Text] [Related]
5. Biotransformation of fluroxene in man.
Gion H; Yoshimura N; Holaday DA; Fiserova-Bergerova V; Chase RE
Anesthesiology; 1974 Jun; 40(6):553-62. PubMed ID: 4151440
[No Abstract] [Full Text] [Related]
6. Distribution and fate of trifluoroethanol in rats.
Airaksinen MM; Kurki M; Rosenberg PH; Idänpään-Heikkilä JE; Walker K
Ann Med Exp Biol Fenn; 1971; 49(2):79-83. PubMed ID: 5570624
[No Abstract] [Full Text] [Related]
7. A note on the biotransformation of fluroxene in two volunteers.
Blake DA; Cascorbi HF
Anesthesiology; 1970 Jun; 32(6):560. PubMed ID: 4393258
[No Abstract] [Full Text] [Related]
8. Studies with halothane. I. The distribution and excretion of halothane metabolites in animals.
Topham JC; Longshaw S
Anesthesiology; 1972 Sep; 37(3):311-23. PubMed ID: 5051609
[No Abstract] [Full Text] [Related]
9. Differences in the biotransformation of halothane in man.
Cascorbi HF; Blake DA; Helrich M
Anesthesiology; 1970 Feb; 32(2):119-23. PubMed ID: 5414289
[No Abstract] [Full Text] [Related]
10. A review of current advances in metabolism of inhalation anesthetics.
Brown BR; Vandam LD
Ann N Y Acad Sci; 1971 Jul; 179():235-43. PubMed ID: 4398307
[No Abstract] [Full Text] [Related]
11. Effect of fluoro compounds on metabolic control in brain mitochondria.
Gál EM
Ciba Found Symp; 1971; 2():77-93. PubMed ID: 5212160
[No Abstract] [Full Text] [Related]
12. Halothane biotransformation in man: a quantitative study.
Rehder K; Forbes J; Alter H; Hessler O; Stier A
Anesthesiology; 1967; 28(4):711-5. PubMed ID: 6028060
[No Abstract] [Full Text] [Related]
13. Biotransformation of halothane.
Rehder K; Sessler AD
Int Anesthesiol Clin; 1974; 12(2):41-53. PubMed ID: 4603051
[No Abstract] [Full Text] [Related]
14. Species and individual differences in the rate of halothane metabolism to trifluoroacetic acid.
Karashima D; Hirokata Y; Mikuriya K; Shigematsu A
Fukuoka Igaku Zasshi; 1979 Jan; 70(1):18-22. PubMed ID: 105979
[No Abstract] [Full Text] [Related]
15. Metabolic effects of commercial beta-glucuronidase preparations on estrogens.
Roy S; Slaunwhite WR
Steroids; 1970 Jul; 16(1):69-78. PubMed ID: 5471536
[No Abstract] [Full Text] [Related]
16. Animal toxicity of 2,2,2-trifluoroethanol.
Blake DA; Cascorbi HF; Rozman RS; Meyer FJ
Toxicol Appl Pharmacol; 1969 Jul; 15(1):83-91. PubMed ID: 5808208
[No Abstract] [Full Text] [Related]
17. Metabolism in dogs of the chloro- and trifluoromethyl-analogues of a piperazine-substituted dihydrobenzoxazepine.
Dreyfuss J; Ross JJ; Shekosky JM; Schreiber EC
Xenobiotica; 1971 Jan; 1(1):29-41. PubMed ID: 5163174
[No Abstract] [Full Text] [Related]
18. Metabolism of catechol estrogen ethers in man.
Yoshizawa I; Fishman J
J Clin Endocrinol Metab; 1970 Sep; 31(3):324-30. PubMed ID: 5453326
[No Abstract] [Full Text] [Related]
19. Letter: "Hepatitis after use of two different fluorinated anesthetic agents".
Anesth Analg; 1975; 54(1):125-32. PubMed ID: 1167748
[No Abstract] [Full Text] [Related]
20. Quantitative analysis of trifluoroacetate in the urine and blood by isotachophoresis.
Morio M; Fujii K; Takiyama R; Chikasue F; Kikuchi H; Ribarić L
Anesthesiology; 1980 Jul; 53(1):56-9. PubMed ID: 7386909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
